Chandrima Sanyal
iShares Genomics Immunology and Healthcare ETF
IDNA · ETF
$40.91−$0.13 (−0.32%)TodayMarket closed ·
Prev close $41.04
About IDNA
- Issuer
- iShares
- Tracks
- NYSE FactSet Global Genomics and Immuno Biopharma Index
- Expense ratio
- 0.47%
- Assets under management
- $331.83M
- Inception
- Jun 11, 2019
- Asset class
- Equity
- Website
- ishares.com
IDNA key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 200.42K
- Volume
- 76.00K
- Open price
- $40.71
- High today
- $41.15
- Low today
- $40.14
- 52 Week high
- $43.44
- 52 Week low
- $24.29
iShares Genomics Immunology and Healthcare ETF (IDNA) at a glance
As of Oct 23, 2026, iShares Genomics Immunology and Healthcare ETF (IDNA) shares are priced at $40.91, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.
Today the fund has traded between $40.14 and $41.15. The current price is 1.9% above the day's low and 0.6% below its high.
Volume so far is 76.00K shares, below the average of 200.42K shares a day.
Over the past year iShares Genomics Immunology and Healthcare ETF has ranged from $24.29 to $43.44, and now sits 87% of the way up that range.
IDNA news
- Chandrima Sanyal
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For
- Lekha Gupta
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
- Chandrima Sanyal
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
- Michael Juliano
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.